000			02302 a2200697 4500
005			20250515153324.0
264		0	_c20090707
008			200907s 0 0 eng d
022			_a1931-3543
024	7		_a10.1378/chest.08-1881 _2doi
040			_aNLM _beng _cNLM
100	1		_aBarnett, Christopher F
245	0	0	_aTreatment of sarcoidosis-associated pulmonary hypertension. A two-center experience. _h[electronic resource]
260			_bChest _cJun 2009
300			_a1455-1461 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Intramural
650	0	4	_aAdministration, Inhalation
650	0	4	_aAdministration, Oral
650	0	4	_aAged
650	0	4	_aAntihypertensive Agents _xadministration & dosage
650	0	4	_aBosentan
650	0	4	_aCohort Studies
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEpoprostenol _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHumans
650	0	4	_aHypertension, Pulmonary _xdrug therapy
650	0	4	_aIloprost _xadministration & dosage
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLinear Models
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPiperazines _xadministration & dosage
650	0	4	_aProbability
650	0	4	_aPurines _xadministration & dosage
650	0	4	_aRespiratory Function Tests
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Assessment
650	0	4	_aSarcoidosis _xcomplications
650	0	4	_aSeverity of Illness Index
650	0	4	_aSildenafil Citrate
650	0	4	_aStatistics, Nonparametric
650	0	4	_aSulfonamides _xadministration & dosage
650	0	4	_aSulfones _xadministration & dosage
650	0	4	_aSurvival Rate
650	0	4	_aTreatment Outcome
700	1		_aBonura, Eric J
700	1		_aNathan, Steven D
700	1		_aAhmad, Shahzad
700	1		_aShlobin, Oksana A
700	1		_aOsei, Kwabena
700	1		_aZaiman, Ari L
700	1		_aHassoun, Paul M
700	1		_aMoller, David R
700	1		_aBarnett, Scott D
700	1		_aGirgis, Reda E
773	0		_tChest _gvol. 135 _gno. 6 _gp. 1455-1461
856	4	0	_uhttps://doi.org/10.1378/chest.08-1881 _zAvailable from publisher's website
999			_c18568070 _d18568070